Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibitionLeonid Cherkassky, Prasad S. Adusumilli|Journal of Clinical Investigation|2016Cited by 1k
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent PembrolizumabPrasad S. Adusumilli, Michel Sadelain|Cancer Discovery|2021Cited by 551
c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulationYuquan Xiong, Prasad S. Adusumilli|Nature Cancer|2023Cited by 18